Cargando…
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
Heparanase promotes tumor growth in breast tumors. We now evaluated heparanase protein and gene-expression status and investigated its impact on disease-free survival in order to gain better insight into the role of heparanase in ER-positive (ER+) breast cancer prognosis and to clarify its role in c...
Autores principales: | Zahavi, Tamar, Salmon-Divon, Mali, Salgado, Roberto, Elkin, Michael, Hermano, Esther, Rubinstein, Ariel M., Francis, Prudence A., Di Leo, Angelo, Viale, Giuseppe, de Azambuja, Evandro, Ameye, Lieveke, Sotiriou, Christos, Salmon, Asher, Kravchenko-Balasha, Nataly, Sonnenblick, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163849/ https://www.ncbi.nlm.nih.gov/pubmed/34050190 http://dx.doi.org/10.1038/s41523-021-00277-x |
Ejemplares similares
-
SYK expression level distinguishes control from BRCA1-mutated lymphocytes
por: Zahavi, Tamar, et al.
Publicado: (2018) -
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
por: Anabel Sinberger, Liat, et al.
Publicado: (2023) -
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model
por: Zahavi, Tamar, et al.
Publicado: (2015) -
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
por: Raphael, Ari, et al.
Publicado: (2022) -
Heparanase augments insulin receptor signaling in breast carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2016)